Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock moved upwards by 68.1% to $6.59 during Tuesday’s after-market session. Kala Pharmaceuticals’s trading…
Gainers
OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Gainers
Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings came out 2 days ago.